DADarcy Adin

Darcy Adin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Darcy Adin has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    EXPRESS: Renin-Angiotensin-Aldosterone System Profiling in a Cat with Primary Hyperaldosteronism

    by Samantha Scott, Emma K LaVigne, Sophie Cormillot, Eduardo J Benjamin, Darcy Adin

    Case Summary: A 17-year-old female spayed domestic shorthair cat was presented for evaluation of systemic hypertension, hypokalemia, and cervical ventroflexion. Abdominal ultrasonography identified a right adrenal mass. Increased serum aldosterone concentration by radioimmunoassay (2786 pmol/L) supported primary hyperaldosteronism, but the cat was receiving amlodipine, a renin-angiotensin-aldosterone system (RAAS)-activating medication, which can increase serum aldosterone concentrations. Equilibrium analysis evaluation of the RAAS showed markedly elevated aldosterone (2137 pmol/L) without elevated angiotensin II. The ratios of aldosterone to angiotensin II and to plasma renin activity surrogate were markedly increased, supporting aldosterone secretion that was inappropriate relative to the other RAAS components. The cat underwent right adrenalectomy and histopathology which confirmed adrenal adenocarcinoma. Relevance and novel information: The congruence of comprehensive RAAS analysis with currently accepted testing used to support the diagnosis of aldosterone-secreting neoplasia in the cat of this report supports future research into the potential clinical utility of RAAS profiling to diagnose primary hyperaldosteronism in cats, even when receiving RAAS-modifying medications.

  • Open Access

    Patient safety investigative methods identify contributors to canine magnetic resonance imaging dermatologic thermal injuries in an academic hospital

    by Darcy Adin, Corey Stockhaus, Taylor Reyes, Domenico Santoro, Chris Sanchez, Marta Romano, Mary Wilson, Aitor Gallastegui, Linda Allen, Aline Rodrigues Hoffmann

    Objective: To describe MRI-associated ECG electrode site thermal burns in dogs and the patient safety investigation that identified a reduction of radiofrequency energy output as a modifiable factor associated with their resolution. Animals: 10 client-owned dogs undergoing MRI that experienced skin lesions at the ECG electrode site from April through December 2024. Clinical Presentation: The reason for MRI was brain imaging in 5 dogs, spine imaging in 4 dogs, and both brain and spine imaging in 1 dog. Median weight was 14.7 kg (range, 3.1 to 31.5). Median age was 9 years (range, 1 to 13). Results: After an MRI upgrade, 10 dogs experienced skin lesions consistent with thermal injury at the ECG electrode site. Thermal injury was mild (7) and moderate to severe (3). Two dogs underwent skin biopsy, which confirmed second-degree burns. A comprehensive, systematic, iterative approach to investigate these patient harm events was undertaken, involving multiple investigations and procedural changes. Resolution came after MRI radiofrequency energy output was reduced despite being measured in the acceptable range. Clinical Relevance: The approach used to investigate MRI-associated thermal burns in this study highlights the importance of identifying root causes to improve system safety and ultimately prevent future harm. Histologic confirmation of thermal injury has not previously been reported in dogs and was important because it refocused the investigation on MRI output as a potential cause.

  • Open Access

    Hypochloremia is negatively associated with outcomes in cats with stable congestive heart failure

    by Corine Lavigne, Darcy B. Adin, Natasha Gurdyal, Alexis Cooper, Autumn N. Harris

    Objective: To assess the association between serum chloride concentration (s[Cl − ]) and survival outcomes in cats with stable congestive heart failure (CHF). Methods: This was a single-institution retrospective study. Medical record reviews of 178 client-owned cats from 2014 through 2024 identified 84 cats meeting inclusion criteria of stable CHF at least 1 week after hospitalization. Cats with significant gastrointestinal disease were excluded. Biochemical parameters, medications, and survival were analyzed using Kaplan-Meier methods. Forward stepwise Cox proportional hazards regression was used to identify independent predictors of death risk. Results: Hypochloremia was defined as s[Cl − ] < 112 mEq/L (the lower limit of the reference range). Fifteen cats were hypochloremic, and 69 cats were normochloremic. Hypochloremia was independently associated with a higher risk of death (hazard ratio, 2.82), and survival was shorter for cats with s[Cl − ] < 112 mEq/L (159 days) compared to cats with s[Cl − ] > 112 mEq/L (392 days). Diuretic dose was significantly higher in the hypochloremic group but was not an independent predictor of outcome in multivariable modeling. Two other confounders independently predicted outcome in the multivariable model (higher death risk with pimobendan use; hazard ratio, 1.96; lower death risk with normal BUN < 28 mg/dL; hazard ratio, 0.45). Conclusions: In this cohort of cats with stable CHF, hypochloremia was independently associated with significantly shorter survival and increased mortality risk. Clinical Relevance: Efforts to normalize s[Cl − ] in cats with CHF merit consideration.


  • Open Access

    Moderate to severe hypochloremia is associated with shortened survival in dogs with stable congestive heart failure

    by Dylan J. DeProspero, Autumn N. Harris, Alexis Cooper, Darcy B. Adin

    Objective: To retrospectively evaluate hypochloremia as a predictor of poor outcomes for dogs with congestive heart failure (CHF). Methods: A single-institution retrospective study including dogs diagnosed with CHF between 2014 and 2024. Biochemical variables, medications, and outcome data were extracted from medical records at the first recheck after the initial CHF episode. Exclusion criteria were active CHF, absence of serum chloride concentration (s[Cl]) on bloodwork, reliance on point-of-care bloodwork alone, major interventional procedures (eg, mitral valve repair), and clinically important vomiting or diarrhea. Dogs were grouped by s[Cl] < 100 or ≥ 100 mEq/L. Associations between s[Cl] < 100 mEq/L, biochemical variables, medications, and risk of death were evaluated with a Cox proportional hazards model. Survival was assessed with a Kaplan-Meier analysis and compared with a log-rank test. Results: A total of 292 stable CHF dogs were included (229 degenerative valve disease, 31 dilated cardiomyopathy, 21 congenital heart disease, 6 pulmonary hypertension, and 5 arrhythmogenic cardiomyopathy). Median s[Cl] was 106.5 mEq/L (range, 85.0 to 119.0 mEq/L). Dogs with s[Cl] < 100 mEq/L had a significantly increased risk of death (HR, 2.649; 95% CI, 1.265 to 5.311) and shortened survival (median survival, 115 days) compared to dogs with s[Cl] ≥ 100 mEq/L (median survival, 196 days). No other biochemical variables or medications were significantly associated with survival. Conclusions: Moderate to severe hypochloremia (s[Cl] < 100 mEq/L) in dogs with stable CHF is associated with worse survival compared to dogs with s[Cl] ≥ 100 mEq/L. Clinical Relevance: These findings support clinical efforts to correct and maintain serum chloride concentrations above 100 mEq/L in dogs with CHF.


  • Open Access

    Twenty-Four-Hour Electrocardiographic Monitoring for Assessment of Cardiac Arrhythmias in Healthy and Hospitalized Goats

    by Alyssa Sullivan, Darcy B. Adin, Sara B. Speziok, Dana Haimovitz, Todd C. Holbrook, Daniela Luethy

    Background: Continuous 24-h electrocardiographic (ECG) recording is a well-established method for the detection of intermittent arrhythmias in veterinary medicine. The clinical utility of 24-h ECG for the detection of intermittent arrhythmias in hospitalized goats has not been reported. Hypothesis/Objectives: (1) Determine the clinical feasibility of continuous 24-h ECG monitoring in goats; (2) Report the frequency of ventricular arrhythmias in healthy and hospitalized medically ill goats. Animals: Eleven healthy goats, 20 hospitalized medically ill goats. Methods: Prospective clinical study. Continuous 24-h ECG recordings were performed. Electrocardiograms were analyzed for rhythm diagnosis. The number of ventricular premature depolarizations (VPD) was compared between groups using the Wilcoxon rank sum test. Results: The ECG monitors were well-tolerated in 30/31 goats, with no adverse effects. Twenty-eight recordings were of sufficient quality for analysis with a median readable time of 23 h (range, 15–24 h). Eleven goats had ventricular arrhythmias (4 healthy, 7 medically ill), consisting of single VPDs only in 7 goats (3 healthy, 4 medically ill), VPDs and ventricular couplets in 4 goats (1 healthy, 3 medically ill), and ventricular rhythm consistent with accelerated idioventricular rhythm (AIVR) or ventricular tachycardia in 2 goats (2 medically ill). A significant difference in the number of VPDs in healthy goats (median, 0; range, 0–9) and medically ill goats was not identified (median, 0; range, 0–201; p = 0.66), but a larger sample size is required. Conclusion and Clinical Importance: Most goats tolerated 24-h ECG monitoring well, although a few recordings were of poor quality. Ventricular arrhythmias were seen in healthy and medically ill goats.

  • Open Access

    Clinical Outcomes of Mitral Valve Repair in Dogs With Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease

    by Tomohiko Yoshida, Darcy Adin, Katsuhiro Matsuura

    Background: Myxomatous mitral valve disease (MMVD) can cause pulmonary hypertension (PH). Mitral valve repair (MVR) has been described as a surgical treatment option for MMVD, but the benefit of MVR when PH is present is unknown. Hypothesis/Objectives: To investigate the change in echocardiographic variables and long-term outcomes of dogs with PH secondary to MMVD after MVR. Animals: Twenty-one dogs with PH secondary to MMVD that underwent MVR. Methods: Inclusion criteria were MMVD dogs that had a high probability of PH according to the metrics established in the American College of Veterinary Internal Medicine (ACVIM) consensus statement on PH in dogs, and that had two follow-up evaluations. Echocardiographic variables before MVR were compared with the follow-up evaluations after surgery. Results: Before surgery, 12 dogs were Stage C whereas 9 dogs were Stage D. Echocardiographically normalized left ventricular internal diameter in diastole (LVIDDN), mitral E wave velocity, the ratio of the left atrial dimension to the aortic annulus dimension (LA/Ao) and tricuspid regurgitation velocity were significantly decreased after surgery (p < 0.01). Complete resolution of preoperative clinical signs was achieved in 71.4% of dogs after surgery. However, two dogs had residual PH (9.5%) and three dogs that had resolution of PH post-operatively had recurrent PH (14.2%). Conclusions and Clinical Importance: We showed that most dogs with PH before MVR had decreases in estimated pulmonary arterial pressure after surgery as well as resolution of clinical signs. Some dogs had residual PH and late PH recurrence after MVR, which could suggest underlying pulmonary arterial pathology.


  • Open Access

    Copeptin Hormone Concentrations in Dogs with Heart Disease and Relationship with Antidiuretic Hormone

    by Corine Lavigne, Darcy B. Adin, Courtney Hanner, Alexis Cooper, Rebeca A. Castro, Autumn N. Harris

    Antidiuretic hormone (ADH) is upregulated in dogs with cardiac disease. However, measurement of ADH is impractical in a clinical setting. Copeptin is co-secreted with ADH, making it a potential biomarker of ADH secretion. We hypothesized that dogs with cardiac disease would upregulate copeptin concentrations and that copeptin would positively correlate with ADH, serum chloride ([Cl−]), and degree of mathematical [Cl−] correction. The study population comprised 19 healthy, 20 preclinical (Stage B), and 20 congestive heart failure (CHF, Stage C or D) dogs. Groups were compared with Kruskal–Wallis tests. The agreement between ADH and copeptin was assessed with Bland–Altman analysis. Relationships between copeptin and clinical variables were explored using multivariable linear regression. There were no significant differences in copeptin concentrations among healthy (median 54.9 pg/mL; range 0.5–196.1), preclinical (median 43.6 pg/mL; range 0.5–131.4), and CHF (median 60.5 pg/mL; range 0.5–997.8) dogs (p = 0.76). Relative to ADH, copeptin showed a negative proportional bias of −87.8 pg/mL with wide limits of agreement (−421.8 to 246.2). Linear regression showed a significant influence of age on copeptin concentration. Copeptin measured by ELISA does not reflect the ADH concentration in healthy dogs or in dogs with cardiac disease. Copeptin concentrations are, however, inversely associated with age.


  • Open Access

    Renin-Angiotensin-Aldosterone System Profiling in Horses Before and After Exercise

    by Todd Holbrook, Jorge Hernandez, Taralyn McCarrel, Guy Lester, Margaret Sleeper, Oliver Domenig, Darcy Adin

    Background: The impact of exercise on the classical and alternative renin-angiotensin-aldosterone system (RAAS) pathways has not been studied in horses. Hypothesis: We hypothesized that exercise would activate both RAAS pathways and that endurance exercise would cause more activation of the classical pathway compared to short-duration, high-intensity exercise in horses. Animals: Twenty-five horses (21 client-owned and 4 research) were included in 4 exercise groups (10 Arabians, 50-mile ride [A-E]; 4 thoroughbreds, 1-mile treadmill exercise [TB-TM]; 5 thoroughbreds, 1–1/16th-mile race [TB-R]; and 6 quarter horses 330-500-yard race [QH-R]). Methods: Blood was collected before and after exercise. Equilibrium analysis was performed to measure serum RAAS metabolites and enzyme activities. The components of the RAAS pathways were compared before and after exercise. Post/pre-exercise ratios for each variable were compared among exercise groups. Data were reported as median (first, third quartiles; pre vs. post) and p < 0.05 was considered significant. Results: Exercise increased classical RAAS metabolites (pmol/L; angiotensin I, 2.5 [2.5, 2.5] vs. 8.2 [2.5, 19.0]; angiotensin II, 10.2 [6.0, 21.9] vs. 53.0 [37.4, 95.8]; aldosterone, 83.8 [53.4, 149.5] vs. 170.6 [112.2, 251.7]); alternative RAAS metabolites (pmol/L; angiotensin 1–7, 1.5 [1.5, 1.5] vs. 5.1 [1.5, 12.5]; angiotensin 1–5, 2.5 [2.5, 7.3] vs. 14.9 [9.0, 25.4]) and angiotensin-converting enzyme-2 activity (ng/mL; 16.6 [13.9, 20.4] vs. 25.2 [20.2, 33.0]; p < 0.001) for all horses. Angiotensin 1–7 ratios were higher for TB-R compared with TB-TM and A-E (p < 0.001). Conclusions and Clinical Importance: Both classical and alternative RAAS pathways increase after exercise in horses.